Bioscience

Zynex obtains patent for Blood Volume Monitor

Zynex obtains patent for Blood Volume Monitor

ENGLEWOOD -- Zynex, Inc . (OTCQB: ZYXI), a medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac... Read More

Tuesday October 9, 2018 0 comments Tags: Englewood, Zynex, Blood Volume Monitor, Thomas Sandgaard

Clarius introduces world's first high-rez wireless endocavity scanner

Clarius introduces world's first high-rez wireless endocavity scanner

DENVER -- Clarius Mobile Health is introducing the EC7 Endocavity Ultrasound Scanner, a wide-band microconvex array, to improve the gynecologic and urological procedure workflow. Like... Read More

Tuesday October 9, 2018 0 comments Tags: Denver, Clarius Mobile Health, Endocavity Ultrasound Scanner, Kris Dickie

Front Range Biosciences raises $10M in Series A funding round, largest by cannabis biotech company

Front Range Biosciences raises $10M in Series A funding round, largest by cannabis biotech company

BOULDER -- Front Range Biosciences , a leading agricultural biotech company specializing in tissue culture propagation of high-value crops, today announced it completed a$10 millionSeries A... Read More

Friday October 5, 2018 0 comments Tags: Boulder, Front Range BioSciences, Jonathan Vaught

Paragon 28 releases new foot plating options

Paragon 28 releases new foot plating options

ENGLEWOOD -- Paragon 28 announced it has launched innovative new products and instrumentation that help to streamline procedures, allow foot surgeons flexibility in technique and approach,... Read More

Thursday October 4, 2018 0 comments Tags: Englewood, Paragon 28

Clovis Oncology receives Breakthrough Therapy designation for Rubraca

Clovis Oncology receives Breakthrough Therapy designation for Rubraca

BOULDER -- Clovis Oncology, Inc. (NASDAQ: CLVS) today announced theU.S. Food and Drug Administration(FDA) has granted Breakthrough Therapy designation for Rubraca (rucaparib) as a monotherapy... Read More

Tuesday October 2, 2018 0 comments Tags: Boulder, Clovis Oncology, Rubraca, Patrick J. Mahaffy, FDA

CU discovery could revitalize antibiotics to better fight superbugs

CU discovery could revitalize antibiotics to better fight superbugs

BOULDER -- With antibiotic-resistant superbugs now infecting 2 million people per year and a dearth of new medications in the pipeline to treat them, University of Colorado Boulder researchers... Read More

Monday September 24, 2018 0 comments Tags: Boulder, CU Boulder, Corrie Detweiler, Colorado OEDIT

European Commission approves Array's encorafenib and binimetinib combo for melanoma treatment

European Commission approves Array's encorafenib and binimetinib combo for melanoma treatment

BOULDER -- Array BioPharma Inc . (NASDAQ: ARRY) today announced the European Commission (EC) has approved BRAFTOVI (encorafenib) in combination with MEKTOVI (binimetinib) for the treatment of... Read More

Friday September 21, 2018 0 comments Tags: Denver, Array BioPharma, Ron Squarer, encorafenib, binimetinib

CBSA awards dinner set for Nov. 8 to honor state’s bioscience leaders

CBSA awards dinner set for Nov. 8 to honor state’s bioscience leaders

DENVER -- Colorado BioScience Association (CBSA) will hold its 15 th annual CBSA Awards Dinner on Nov. 8. The event acknowledges the achievements in the states bioscience industry over... Read More

Thursday September 20, 2018 0 comments Tags: Denver, CBSA, CBSA Annual Awards Dinner